Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is seeking a Director, Patient Advocacy & Society Engagement to lead patient advocacy, professional society engagement, and expanded access program/compassionate use work in Europe. The role will report to the Global Head of Advocacy and Society Engagement and play a key part in driving RevMed’s strategy in the EU.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines